Bortezomib improves initial treatment response in multiple myeloma

9 September 2008 Print this article Comments Share this article
Results of a European Group (VISTA) shows that adding bortezomib to melphalan and prednisone improves initial response in myeloma patients over 65 who are unsuitable for high-dose therapy....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites